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Abstract
Background: Pingchuan Formula (PCF) is a traditional Chinese recipe. PCF improves chronic airway inflammation
by correcting the imbalance of T-helper cell ratio. The purpose of this study was to investigate the effect of PCF
on pathological changes in the lungs of asthmatic mice in terms of Treg/Th17 balance.
Methods: A bronchial asthma BALB/c mouse model was established using the ovalbumin excitation method.
Distilled water (for MDL group) and drugs (for DEX or PCF group) were administered by gavage immediately after
the first excitation. Mice were sacrificed after 7 and 28 d treatment. Lung tissues and bronchoalveolar lavage fluid
were collected and lung pathological changes were observed after hematoxylin and eosin staining. Differential
cell counts, concentrations of interleukins-6, -17, -23 and TGF-β in bronchoalveolar lavage fluid were determined
by enzyme-linked immunosorbent assay. Expression of transcriptional factors Foxp3 and RORγt was determined
by immunohistochemistry and immunoblot.
Results: An asthma model was successfully established. After 7 or 28 d treatment, lung pathological changes
were improved and concentration of interleukins-6, -17, -23 and TGF-β in bronchoalveolar lavage fluid significantly
decreased in the PCF group. RORγt expression in lung tissue was decreased in the PCF group, while Foxp3 expression
increased (all P values < 0.05 compared with the MDL group). There was no significant difference between the PCF
and DEX group except that mice in the PCF group lost less bodyweight.
Conclusions: Treatment with PCF downregulates RORγt, elevates Foxp3 expression, reduces interleukins-6, -17, -23 and
TGF-β in bronchoalveolar lavage fluid, thus restoring Th17/Treg balance, improving airway inflammation and reducing
asthma symptoms.
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Background
Asthma is a common, chronic inflammatory disease of
the airways characterized by variable and recurring
symptoms, reversible airflow obstruction, broncho-
spasm and hyper-responsiveness (AHR) [1]. With the
development of biopsies and bronchoalveolar lavage
fluid (BALF) collection technology in the late 1980s, it
is now recognized that the common reason for airway
obstruction in asthma is chronic airway inflammation
[2]. Common symptoms include repeated episodes of
wheezing, coughing, shortness of breath, tightness of
the chest and symptoms previously described by the
National Institutes of Health. Many patients with
asthma experience exacerbations at night and/or early
in the morning. The most prevalent form of inflamma-
tion is allergic pulmonary inflammation, which is initi-
ated by exposure to inhaled allergens and resultant
allergen-specific immune responses. As many individ-
uals are exposed to the same inhaled allergens, but not
all suffer from asthma, it is essential to determine the
pathogenetic pathways of this chronic inflammatory
disease. These pathways have been seen in the murine
model of asthma.
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Many studies have demonstrated a crucial role for T-
lymphocytes and the cytokines produced by T-cells in the
development of allergic asthma [3, 4]. With the develop-
ment of the airway inflammation hypothesis, the disturbed
balance of the T-helper (Th1/Th2) ratio has become a
paradigm in asthma pathogenesis [5]. In addition, the
discovery of the mutual inhibitory effects of Th1 and Th2
cells in mice [6] prompted the postulation that an imbal-
ance between these two branches of the immune response
would underlie Th1-mediated autoimmune diseases as
well as Th2-mediated allergic diseases, including asthma
[7]. It has been reported that in conjunction with increas-
ing numbers of Th2 cells, there is an increase in the
amount of interleukin 4 (IL-4) secreted, a cytokine that
plays a major role in airway allergic inflammation [8]. It is
well known that Th1/Th2 lymphocytes play an important
role in the initiation, progression and persistence of
allergic diseases including asthma. Little is known of the
immunoregulatory mechanisms that determine the sus-
ceptibility to, the severity of, and the persistence of
asthma. Due to its failure to adequately explain many
(pre)clinical observations, many researchers consider the
imbalance of Th1/Th2 in the mechanism underlying in-
flammatory and autoimmune disease to be an antiquated
paradigm [9].
Currently, T-regulatory (Treg) cells have been recog-
nized as crucial immunoregulatory cells, capable of sup-
pressing Th1- and Th2-mediated adaptive immune
responses in a cell contact-dependent fashion [10]. Theor-
etically, Treg cells may interfere with the development of
allergic diseases at different stages, such as allergic
sensitization, progression to allergic inflammation, airway
remodeling and AHR as well as persistence of disease
manifestations. Treg cells expressing CD25 on CD4 +
cells, which were discovered in 1995 by Japanese scholars,
can negatively regulate activation and proliferation of CD4
+ or CD8+ T cells. Treg cells also inhibit the proliferation
of naive T cells and memory T cells [11]. Recent studies
have also found coexistence of Th1/Th2 and Th17/Treg
imbalances in patients with allergic asthma [12]. Th17
cells are a specific T functional cell group, that play key
roles in mediating autoimmunity, inflammation and mu-
cosal host defense against pathogens [13]. Th17 cells are
largely defined by their eponymous cytokines, IL-17A and
IL-17 F, that are pro-inflammatory by virtue of their direct
and indirect effects on neutrophil recruitment [14]. Whilst
Th17 cells alone do not cause eosinophilic airway inflam-
mation, the IL-23-Th17 cell axis enhances Th2 cell medi-
ated eosinophilic airway inflammation [15]. A novel
member of the IL-12 cytokine family, IL-23 has been iden-
tified as playing an important pathogenic role in chronic
inflammation. It has been reported that IL-23 has effects
on eosinophilic recruitment and is crucial for the main-
tenance of Th17 cells [16].
Recent studies have found that Th17 immunity con-
tributes to the systemic immune responses in allergic
asthmatic patients. Individually, neither IL-17 nor on-
going Th2 responses were sufficient to confer AHR.
However, they act synergistically to promote neutrophil
recruitment, eosinophil recruitment and AHR [17]. The
Forkhead box P3 (Foxp3) transcription factor is the key
driver of Treg cells differentiation and immunosuppres-
sive function. Foxp3+ Treg cells have essential roles in
the maintenance of immune homeostasis and in regula-
tion of effector T cell responses [18]. Foxp3+ Treg cells
co-express retinoic acid receptor-related orphan recep-
tor (ROR) γt (in mice) and secrete high levels of IL-17
ex vivo [16, 19, 20]. In the absence of a second signal
from pro-inflammatory cytokines, Foxp3 can inhibit
RORγt function and drive Treg differentiation [21].
When the cell receives a signal from a proinflammation
cytokine, such as IL-6, Foxp3 function is inhibited and
the Th17 differentiation pathway is induced [21, 22].
A traditional Chinese medicine (TCM) recipe, Pingchuan
Formula (PCF), was first proposed by Professor Yu Jianer
in 1999. This formula consists of several herbs, including
ephedra, almond, perillage semen, raphani semen,, earth-
worm, peach kernel, scutellaria baicalensis and liquorice.
It may regulate the movement of Qi in body, eliminate
sputum and promote blood circulation to relieve the
symptoms of asthma [23]. Previous studies have indicated
that PCF can improve chronic airway inflammation and
inhibit airway remodeling bycorrecting the inbalance of
Th1/Th2 [24]. However, it has remains unknown how
PCF treatment regulates Treg/Th17 cells and their as-
sociated cytokines. The current study was performed to
investigate the effect of PCF on the balance of Treg/
Th17 in an ovalbumin (OVA)-induced asthma mice
model with dexamethasone (DEX) as a positive control.
Airway inflammation and expression of related tran-
scriptional factors Foxp3 and RORγt in lung tissue were
detected in asthmatic mice treated with PCF or DEX
over different time periods.
Methods
Animals
A total of 80 male BALB/c mice, 5 weeks old, 16-19 g
in weight, were purchased from Shanghai Super-B&K
Laboratory Animal Corp. Ltd. (grade SPF, production
license number: SCXK2008-0016). The animals were
housed in a temperature-controlled room at 21–23 °C
and maintained on a 12 h light: 12 h dark cycle. All
experimental procedures were approved by the Animal
Care and Use Sub-committee of the Shanghai Traditional
Chinese Medicine Hospital. The mice were housed in
macrolon cages in a laminar flow cabinet. All mice were
provided with food and water ad libitum.
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Mice grouping
Eighty mice were randomly divided into 4 groups:
control (CON) group (n = 20), model (MDL) group
(asthma induced, no treatment, n = 20), DEX group
(asthma induced, DEX treatment for 7 or 28 d, n = 20)
and PCF group (asthma induced, PCF treatment for 7
or 28 d, n = 20).
Model preparation
The mouse asthma model was established as previously
described [25] with some modifications. Just before use,
a total of 10 g OVA Shanghai Chun Hui Chemical Co.,
batch number: 20120418) and 1 g aluminum hydroxide
were dissolved in 100 ml distilled water to form 10 %
sensitizing liquid. Except for the CON group, animals
were treated with two intraperitoneal (i.p) injections of
50 ml/kg OVA, spaced 2 weeks apart. Twenty four
hours after the last sensitization, the sensitized groups
were challenged with 5 % OVA nebulization, 40 min
each time, once a day for a total of 1 week. Mice in the
CON group were i.p injected and inhaled an equal
amount of distilled water.
Administration of drugs by gavage
The PCF (provided by Shanghai Hospital of TCM) was
prepared to 5.33 g/ml concentration as previously de-
scribed [24]. This was by adding 13 times the volume
of water, boiling it and then simmering for 30 min. The
liquid was than filtered out and 11 times the volume of
water was added for a second round of boiling as be-
fore. The two filtrates obtained from boiling were
mixed and concentrated, an appropriate amount of
95 % ethanol (calculated according to the formula V *
60/ (95 -60) was added, and refrigerated for 24 h. Then
the filtrate was concentrated into liquid extracts. The
composition of PCF is as follows: Honey Licorice (9 g);
Scutellaria Baicalensis Georgi (9 g); Honey Perilla Seed
(9 g); Semen Raphani (9 g); Bitter Apricot Seed (9 g);
Peeled Peach Kernel (9 g); Honey Ephedra (6 g); Earth-
worm (9 g). The estimated chemical formula is therefore
based upon the following information from According to
the Pharmacopoeia of People’s Republic of China: (2010
edition, published by China Pharmaceutical Science and
Technology Press). Honey Herba Ephedraev (after desic-
cation), contains no less than 0.80 % of ephedrine hydro-
chloride and pseudoephedrine hydrochloride in weight.
Scutellaria baicalensis (after desiccation), contains no less
than 9 % baicalin. Perilla Seed (after desiccation) contains
not less than 0.25 % of rosmarinic acid, which is the main
component. Semen Raphani, contains no less than 0.40 %
of sinapine (calculated by sinapine thiocyanate instead),
which is the main component. The main component of
earthworm is protein, and lysine, leucine, valine were used
as reference substances in content determination. The
main component of Bitter Apricot Seed is laetrile (no less
than 2.4 %). The main component of Peeled Peach Kernel
is laetrile (no less than 2 %). Honey Licorice contains
liquiritin (no less than 0.50 %) and glycyrrhizic acid (no
less than 1 %).
DEX (Shanghai Xinyi Co., Ltd., batch number; 110302)
was prepared to a concentration of 0.075 mg/ml. Mice
in the CON and MDL groups were provided with
distilled water whilst mice in the DEX and PCF groups
were fed 20 ml/kg DEX or PCF, respectively. Mice were
observed and weighed daily to ensure the correct dose
of drug was administered. The weight was recorded
periodically. All groups were divided into two and
sacrificed at either 7 or 28 d of treatment, respectively
and specimens of bronchoalveolar lavage fluid (BALF),
blood and lung tissue collected.
Assessment of clinical symptoms of asthma
The clinical signs of asthma in the mice were investi-
gated at day 7 after OVA challenge. These symptoms
included panic and easy irritation, cold aversion and
tendency to clump together, abdominal muscle spasm,
ruffled hair, oral and nasal cyanosis, and shortness of
breath. Each symptom present in a mouse was scored 1
or 0 if not present. A total score of 6 meant that all
symptoms were present.
Differential cell counts in bronchoalveolar lavage fluid
(BALF)
Mice were killed, the chest opened with 22 g catheter in-
tubation, the right main bronchus ligated, and the mice
douched 3 times with 0.3 ml cold phosphate buffered sa-
line (PBS) [French PBS buffer solution (pH7.2 ~ 7.4)].
The liquid was then siphoned and immediately placed
on ice. The BALF was filtered through sterile gauze to
remove mucous strands, centrifuged (German Eppendorf
Centrifuge Model: 5804R) at 200 g for 5 min at 4 °C and
assayed for differential cell counts including eosinophils
(EOS) and neutrophils (NE) using an enzyme-linked
immunosorbent assay (ELISA) kit as per the manufac-
turer’s instructions (mouse Eotaxin ELISA Kit and GCP-
2 ELISA Kit, RD, US).
Immunological assays
The concentrations of IL-6, IL-17, IL-23 and TGF-β in
BALF were measured using sandwich ELISA kits (ELISA
Kit R&D Systems, Minneapolis, MN, USA) according to
the manufacturer’s instructions.
Hematoxylin and Eosin (H&E) staining of lung tissue
The upper lobe of the right lung was removed and
placed into a cryovial. 10 % Formalin was added to the
tube to fix the lung and it was then prepared for biopsy
sectioning. Paraffin-embedded lung sections (Microtome
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Leica RM2235, 5 μm thick) were stained with hematoxylin
and eosin(H&E) and lung structure evaluated by an
experienced pathologist using microscopic observation
(Olympus BX51, Tokyo, Japan).
Immunohistochemistry (IHC) assay of lung tissue
Immunohistochemical (IHC) staining of lung samples
was performed by a pathologist as previously described
[24]. Briefly, paraffin-embedded lung sections (5 μm
thick) were cut and placed onto silanized glass slides
and air dried before being fixed in cold acetone for
10 min. Sections were then rehydrated in PBS for
10 min and blocked in PBS containing 10 % mouse
serum for 30 min in a humidified chamber Friocell
Germany MMM incubator (37 °C). Both Foxp3 and
RORγt were probed with FITC-conjugated rat anti-
mouse monoclonal antibodies (anti-Foxp3: 47 kDa,
Epitomics, US; anti-RORγt: 52 kDa, Millipore, US) and
visualized using confocal microscopy (Olympus Fluo-
view 500, Tokyo, Japan) with an excitation wavelength
of 488 nm and an emission range of510-550 nm. The
FITC-conjugated nonspecific rat IgG isotype control
was used as a negative control.
Immunoblot assay
Lung fragments (0.05 g) were homogenized in ice-cold
RIPA lysis buffer (Beyotime, China) and protein concen-
trations determined using the BCA protein Assay Kit
(Beyotime, China) with the absorbance read on a Bio-Rad
680 microplate reader (Bio-Rad, USA). Proteins were sep-
arated using the 10 % SDS-PAGE method (Mini-protean 3
Dodeca cell, Bio-Rad, Hercules, CA). The protein was
then transferred onto a polyvinylidenedifluoride mem-
brane (Bio-Rad, Hercules, CA). A pre-stained marker was
utilized to determine the separation of proteins. The
membrane was probed with anti-Foxp3 or anti-RORγt
monoclonal antibodies, followed by alkaline phosphatase-
conjugated secondary antibodies (BD, USA). Protein was
visualized using the brightening agent, ECLTM western
blotting detection (GE healthcare, No. RPN2106), and
protein band intensity was quantified using the Gel-Pro
imaging software (Media Cybernetics, Silver Spring, MD).
Statistics
Statistical analysis was performed with SPSS 18.0 soft-
ware (SPSS, Chicago, IL). If the data followed a normal
distribution and homogeneity of variance, a one way
analysis of variance (ANOVA) and least significant dif-
ference (LSD) multiple comparison were used. 2 × 2
factorial design analysis was also employed. A value of
P < 0.05 was considered significant.
Results
Comparison of survival situation among groups
There was no significant difference in the weight of the
animals before being challenged. Following OVA excita-
tion for 7 or 28 d of treatment, the bodyweights of the
DEX group were significantly reduced compared with
the CON group (P <0.05) (Table 1), while there was no
significant difference between PCF and CON groups
(P > 0.05).
The mice in the MDL group showed different degrees
of anxiety, muscle twitching, urinary and fecal incontin-
ence, hair fluffing, activity decrease, appetite reduction,
oronasal cyanosis and shortness of breath. DEX and
PCF groups were roughly similar. Quantification of the
symptoms showed that the CON group had a mean
score of 0.40 ± 0.50, all of the experimental groups
showed significantly higher values (P < 0.05); the MDL
group with 5.15 ± 0.59, DEX with 4.40 ± 0.82, and PCF
with 4.05 ± 0.76. The values for the DEX and PCF
groups were similar but significantly lower than the
MDL group (P < 0.05).
Comparison of pathological changes among groups after
7 d of OVA excitation and 7 or 28 d of treatment
Mice in the CON group had smooth, intact bronchial
structure and bronchial epithelial cells were arranged in
neat rows. The thickness of the bronchus was normal.
There was no inflammatory infiltration around the
bronchus. The lumen and peritubular areas had no ob-
vious abnormalities. The MDL group showed bronchial
deformation, narrow in diameter, wall structure damage
and a large number of inflammatory exudate in the
lumen. Bronchial epithelial cells were disordered; goblet
cells were hyperplastic and thickened; the bronchus
cavity had a chrysanthemum-shaped change. There was
infiltration of inflammatory cells around the bronchus,
such as eosinophils / neutrophils. There were a large
number of inflammatory cell infiltration and accumula-
tion in the perivascular area. The overall condition in
the DEX and PCF groups improved slightly compared
with the MDL group. The bronchial structure in both
Table 1 Bodyweight of mice in the four groups before challenge
and after 7 d of OVA excitation and 28 d of treatment. (x  s, g)
Group Before challenge Treated for 7 d Treated for 28 d
n = 20 n = 10 n = 10
CON 17.10 ± 1.37 22.90 ± 1.10 24.10 ± 1.10
MDL 17.80 ± 0.79 20.90 ± 2.77a 23.40 ± 1.58
DEX 17.20 ± 1.23 18.80 ± 0.92ab 18.40 ± 1.27ab
PCF 17.10 ± 1.20 21.10 ± 1.20c 23.30 ± 1.25c
acompared with CON group, P < 0.05; b compared with MDL group, P < 0.05;
ccompared with DEX group, P < 0.05. OVA ovalbumin, CON control group, MDL
asthma model group without treatment, DEX dexamethasone treated group
and PCF Pingchuan Formula treated group
Liu et al. BMC Complementary and Alternative Medicine    Page 4 of 11
the DEX and PCF groups was well-preserved, and cells
were arranged in neat rows and the diameter was normal.
There was a small amount of inflammatory exudate in the
trachea and perivascular area (Fig. 1).
The difference of differential cell counting in BALF
EOS were the major type of cells in BALF in the acute and
sub-acute stages (day 7 and day 28). EOS and NE cells
were detected using ELISA in BALF of mice (n = 6 for
each group) which was administrated 7 or 28 d of PCF/
DEX. The data showed that sensitized mice in the MDL
group had extremely high levels of EOS and NE cells. We
also found that PCF groups had decreased EOS and NE
cells in BALF (Fig. 2).
Comparison of Treg / Th17 cytokines IL-6, IL-17, IL-23 and
TGF-β among groups
Groups were compared using analysis of variance
(ANOVA) and LSD (Fig. 3). After 7 d of OVA excita-
tion and 7/28 d of treatment, the MDL group had
higher levels of all cytokines compared with the PCF
and DEX groups (P <0.05), whilst the levels of all cyto-
kines in the PCF and DEX groups were not significantly
different.
Expression of asthmatic airway RORγt and Foxp3 protein
Following 7 d of OVA excitation and 7 or 28 d of treat-
ment, RORγt expression was higher in the MDL group
compared with the CON group, however Foxp3 was
significantly lower in the MDL group compared with the
CON group (P < 0.05, Fig. 3). Both the PCF and DEX
groups had significantly lower RORγt levels but signifi-
cantly higher Foxp3 levels compared with the MDL
group (P < 0.05). There was no significant difference in
RORγt and Foxp3 levels between the PCF and DEX
groups.
Factorial analysis of treatment and time
The DEX and MDL groups were compared using a 2 × 2
factorial design (untreated/treated, treatment for 7/
28 days) in IL-6, IL-17, IL-23, TGF-β levels and RORγt,
Foxp3 expression. The results are presented in Table 2
and show that improvements of IL-23 and TGF-β levels
by DEX treatment were associated with time. The differ-
ence of IL-23/TGF-β concentrations between DEX (28d
-7d) and MDL (28d-7d) is presented in Table 3.
The PCF and MDL groups were also compared using
a 2× 2 factorial design (Table 4). The results indicated
that improvements of IL-23 and TGF-β by PCF treat-
ment were associated with time of treatment. The
difference of IL-23/TGF-β concentrations between PCF
(28d -7d) treatment and MDL (28d-7d) treatment is
presented in Table 5. The data (Table 3 and Table 5)
shows that PCF treatment and increase in the length of
treatment significantly decreased IL-23 compared with
DEX treatment.
Discussion
Whilst glucocorticoid treatment is the primary treat-
ment choice for asthma patients, traditional Chinese
medicine (TCM), used in Asia for centuries, is beginning
to play a role in Western health care as a complemen-
tary and alternative medicine, especially for mild-to-
moderate asthma. There is increasing scientific evidence
supporting the use of TCM for asthma treatment. Chinese
herbal medicines are one of the major components in
TCM practice and are prescribed in hospitals in China as
either monotherapy or complementary therapy to con-
ventional Western therapy. In the present study, PCF
Fig. 1 Pathological changes detected using H&E staining in lung tissue after 7 d of OVA excitation and 7 or 28 d of treatment. a, H&E stained
lung tissues in CON/MDL/DEX/PCF groups after 7 d of excitation with 5 % OVA nebulization (distilled water for CON group) and the daily subsequent
treatment by gavage with distilled water for CON and MDL group, 20 ml/Kg of DEX (0.075 mg/ml) for DEX group and 20 ml/Kg of PCF (5.33 g/ml) for
PCF group, respectively (n = 10 for each group); b, H&E stained lung tissues in CON/MDL/DEX/PCF groups after 7 d of excitation with 5 %
OVA nebulization (distilled water for mice CON group) and 28 d treatment by gavage the same as in panel A (n = 10 for each group)
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Fig. 2 (See legend on next page.)
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successfully decreased the levels of cytokines and re-
stored Treg/Th17 balance in the asthma mouse model,
thus improving airway inflammation and reducing
asthma symptoms. These findings are consistent with
previous reports investigating the efficacy of herbal
interventions for asthma, whereby TCM herbal signifi-
cantly increased forced expired volume in 1 s (FEV1)
levels (P < 0.05) in asthma patients compared with con-
trols [26]. Various different TCM herbal remedies have
also been shown to improve inflammation indices and
cytokines [27–29]. Several clinical studies have revealed
that TCM herbal remedies are of value for the treat-
ment of asthma and are of particular benefit in that
TCM herbal remedies rarely cause adverse reactions and
side effects. In accordance with previous studies investi-
gating other TCM herbal remedies for asthma, namely an-
tiasthma herbal medicine intervention (ASTHMI) [30],
PCF treatment in the current study induced weight gain.
It can be difficult to unravel the active ingredients of
some TCM herbal remedies that are responsible for the
therapeutic effects because of the complex ingredients
and the intended interaction of those ingredients. A
study on another TCM herbal remedy for asthma sug-
gested that Cynodon dactylon (Linn.) contained scopole-
tin, a coumarin from plant roots, as an active ingredient
from densitometry analyses [27]. The long list of potential
active ingredients in PCF include, ephedrine hydrochlor-
ide, pseudoephedrine hydrochloride, baicalin, rosmarinic
acid, sinapine, laetrile, liquiritin and glycyrrhizic acid. Of
these the most obviously related to asthma treatment is
ephedrine hydrochloride, which is an asthma medication,
classed as a bronchodilator, which was commonly used up
to the 1950s [31]. This active ingredient might partly
explain the reduction of asthma symptoms in the treated
mice in this study, but the interaction of the other active
ingredients might have to be unraveled to explain the
decreased the levels of cytokines and restored Treg/Th17
balance. These results support other studies that have
investigated the role of PCF and inflammation where mice
treated with PCF were found to have a corrected imbal-
ance of Th1/Th2 [24], decreased IL-5 and an adjusted
balance of oxidants/antioxidants [32], and children with
asthma have been shown to have reduced IL-4 and IL-13
and increased interferon (INF)-γ [33].
Normal bronchial mucous glands and goblet cells se-
crete only a small amount of mucus to keep the airway
moist. When the airway has been inflamed, including
mucosal edema, mucus secretion, increased permeabil-
ity of the capillary wall, serous will be exuded. At this
time, sputum containing red blood cells, white blood
cells, macrophages, and other fibrins will be exuded.
Mucus, inhalation of dust and some tissue damage will
Fig. 3 Expression of asthmatic airway RORγt and Foxp3 protein after 7 d of OVA excitation and 7 or 28 d of treatment. a, Immunohistochemistry
assay of RORγt and Foxp3 in lung tissues of CON/MDL/DEX/PCF groups after 7 d of excitation and treatment (n = 10 for each group); b, quantitative
analysis of panel (a); c, immunoblot assay of RORγt and Foxp3 in lung tissues of CON/MDL/DEX/PCF groups after 7 d of excitation and treatment
(n = 10 for each group); d, quantitative analysis of panel (c); e-h, data of 28 d of treatments parallel to panel A-D (n = 10 for each group). *compared
with CON group,P < 0.05; # compared with MDL group,P < 0.05; Δ compared with DEX group,P < 0.05
(See figure on previous page.)
Fig. 2 EOS and NE cell levels and Treg/Th17 cytokines levels in BALF after 7 d of OVA excitation and 7 or 28 d of treatment. a, EOS and NE cell
levels detected using ELISA in BALF of CON/MDL/DEX/PCF groups after 7 d of excitation and treatment (n = 6 for each group); b, EOS and NE cell
levels detected using ELISA in BALF of CON/MDL/DEX/PCF groups after 7 d of excitation and 28 d of treatment (n = 6 for each group). c, IL-6,
IL-17, IL-23 and TGF-β levels detected using ELISA in BALF of CON/MDL/DEX/PCF groups after 7 d of excitation and treatment (n = 10 for each
group); d, IL-6, IL-17, IL-23 and TGF-β levels detected using ELISA in BALF of CON/MDL/DEX/PCF groups after 7 d of excitation and 28 d treatment
(n = 10 for each group). *compared with CON group,P < 0.05; # compared with MDL group,P < 0.05; Δ compared with DEX group,P < 0.05
Liu et al. BMC Complementary and Alternative Medicine    Page 7 of 11
be discharged with a cough [24]. From the Western perspec-
tive, sputum is a pathological product of airway inflamma-
tion. In TCM however, phlegm formed due to a disorder in
body fluid metabolism, is closely related with the functioning
of the lung. The purpose of compatibility of PCF is to re-
cover the pulmonary function and regulate the pulmonary
qi. Thereby, it can relieve asthma and reduce phlegm.
This study revealed that in asthma model, pro-
inflammatory cytokines IL-6, IL-17, IL-23 and TGF-β were
increased. The expression of transcriptional factor RORγt
was increased exponentially but Foxp3 was significantly re-
duced. These data indicate an increase in Th17 cells and a
decrease in Treg cells, suggesting an imbalance in Treg/
Th17, consistent with previous studies [34].
Table 2 Factorial analysis [2 × 2 factorial design (untreated/treated, treatment for 7/28 d)] of IL-6, IL-17, IL-23, TGF-β levels and RORγt,
Foxp3 expression between the MDL and DEX groups
Variation Indicator SS df MS F P
Group (difference between MDL and DEX group) IL-6 56480.11 1 56480.11 346.92 <0.001
IL-17 10396.43 1 10396.43 118.14 <0.001
IL-23 168584.56 1 168584.56 329.16 <0.001
TGF-β 197694.57 1 197694.57 88.65 <0.001
RORγt 0.45 1 0.45 27.11 <0.001
Foxp3 0.52 1 0.52 66.39 <0.001
Time (difference between 7 d and 28 d treatment) IL-6 0.11 1 0.11 0.00 0.979
IL-17 1169.06 1 1169.06 13.29 0.001
IL-23 4214.55 1 4214.55 8.23 0.007
TGF-β 21824.31 1 21824.31 9.79 0.003
RORγt 0.04 1 0.04 2.26 0.141
Foxp3 0.01 1 0.01 1.36 0.251
Group *Time IL-6 220.59 1 220.59 1.36 0.252
IL-17 0.20 1 0.20 0.00 0.962
IL-23 4784.55 1 4784.55 9.34 0.004
TGF-β 25241.88 1 25241.88 11.32 0.002
RORγt 0.01 1 0.01 0.49 0.490
Foxp3 0.00 1 0.00 0.04 0.841
SE IL-6 5860.97 36 162.81 – –
IL-17 3167.92 36 88.00 – –
IL-23 18438.26 36 512.17 – –
TGF-β 80284.78 36 2230.13 – –
RORγt 0.59 36 0.02 – –
Foxp3 0.28 36 0.01 – –
A P value <0.05 was considered statistically significant
MDL asthma model group without treatment, DEX dexamethasone treated group, IL-6 interleukin-6, IL-17 interleukin-17, IL-23 interleukin-23, TGF-β transforming growth
factor-beta, RORγt RAR-related orphan receptor gamma, Foxp3 forkhead box P3**
*Group *Time means that both factor "Group" and "Time" are considered simultaneously
Table 3 Difference of IL-23 and TGF-βlevels in BALF between DEX and MDL groups after DEX or distilled water treatment for 7 or 28 d
IL-23 TGF-β
Group Time Mean 28d-7d Time Mean 28d-7d
7d 28d 7d 28d
MDL 121.70 164.11 142.91 42.41 114.31 211.26 162.79 96.95
DEX 13.74 12.39 13.07 -1.35 23.94 20.42 22.18 -3.52
Mean 67.72 88.25 – 20.53 69.13 115.84 – 46.72
DEX - MDL -107.96 -151.72 -129.84 – -90.37 -190.84 -140.61 –
MDL asthma model group without treatment, DEX dexamethasone treated group, BALF bronchoalveolar lavage fluid, IL-23 interleukin-23, TGF-β transforming
growth factor-beta
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In the present study, compared with the CON group,
the MDL group lost bodyweight and exhibited symptoms
after 7 d of excitation. Lung biopsy revealed the airway
structure was damaged, including bronchial deformation,
diameter narrowing. And there was a lot of intraluminal
inflammatory infiltration, perivascular inflammatory cell
infiltration and accumulation. Inflammatory cytokines
increased. The expression of RORγt and Foxp3 was
disturbed with an increase in RORγt and a decrease in
Foxp3. These differences were statistically significant,
indicating that MDL was a successful model group. All
these indexes in the PCF group were improved, and were
statistically significant. The results indicate that PCF has
an effect on the asthma model group. It can reduce IL-6,
Table 4 Factorial analysis [2 × 2 factorial design (untreated/treated, treatment for 7/28 d)] of IL-6, IL-17, IL-23, TGF-β levels and RORγt,
Foxp3 expression between the MDL and PCF groups
Variation Indicator SS df MS F P
Group (difference between MDL and PCF group) IL-6 38352.38 1 38352.38 131.94 <0.001
IL-17 7712.34 1 7712.34 89.54 <0.001
IL-23 128013.36 1 128013.36 227.20 <0.001
TGF-β 99794.91 1 99794.91 38.07 <0.001
RORγt 0.21 1 0.21 16.11 <0.001
Foxp3 0.42 1 0.42 57.65 <0.001
Time (difference between 7 d and 28 d treatment) IL-6 377.41 1 377.41 1.30 0.262
IL-17 261.65 1 261.65 3.04 0.090
IL-23 2497.38 1 2497.38 4.43 0.042
TGF-β 26216.14 1 26216.14 10.00 0.003
RORγt 0.02 1 0.02 1.42 0.241
Foxp3 0.00 1 0.00 0.08 0.786
Group *Time IL-6 1198.32 1 1198.32 4.12 0.050
IL-17 308.50 1 308.50 3.58 0.066
IL-23 7075.54 1 7075.54 12.56 0.001
TGF-β 20936.21 1 20936.21 7.99 0.008
RORγt 0.00 1 0.00 0.08 0.783
Foxp3 0.02 1 0.02 2.85 0.100
SE IL-6 10464.63 36 290.68 – –
IL-17 3100.86 36 86.16 – –
IL-23 20284.27 36 563.45 – –
TGF-β 94369.00 36 2621.36 – –
RORγt 0.46 36 0.01 – –
Foxp3 0.26 36 0.01 – –
A P value <0.05 was considered statistically significant
MDL asthma model group without treatment, PCF Pingchuan Formula treated group, IL-6 interleukin-6, IL-17 interleukin-17, IL-23 interleukin-23, TGF-β transforming
growth factor-beta, RORγt RAR-related orphan receptor gamma, Foxp3 forkhead box P3
*Group *Time means that both factor "Group" and "Time" are considered simultaneously
Table 5 Difference of IL-23 and TGF-βlevels in BALF between PCF and MDL groups after PCF or distilled water treatment for 7 or 28 d
IL-23 TGF-β
Group Time Mean 28d-7d Time Mean 28 d-7 d
7 d 28 d 7 d 28 d
MDL 121.70 164.11 142.91 42.41 114.31 211.26 162.79 96.95
PCF 35.16 24.36 29.76 -10.80 60.16 65.61 62.89 5.45
Mean 78.43 94.24 – 15.81 87.24 138.44 – 51.20
PCF - MDL -86.54 -139.75 -113.15 – -54.15 -145.65 -99.90 –
MDL asthma model group without treatment, PCF Pingchuan Formula treated group, BALF bronchoalveolar lavage fluid, IL-23 interleukin-23, TGF-β transforming
growth factor-beta
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IL-17, IL-23, TGF-β and RORγt expression, and elevate
Foxp3 expression. Compared with the DEX group, PCF
increased bodyweight and was not inferior with the DEX
group in terms of the regulation of IL-6, IL-17, TGF-β,
RORγt and Foxp3.
The PCF and DEX groups were compared with the
MDL group in 2 × 2 factorial analysis. The difference
between the PCF group and the DEX group in the expres-
sion of IL-6, IL-17, RORγt and Foxp3 was simply due to
processing factors. The PCF group and the DEX group
both had cumulative effects on IL-23 and TGF-β. The
PCF group had better accretion than DEX on IL-23.
The current study has several limitations, indicating
the need for future research in the investigation of TCM
herbal remedies for the treatment of asthma. Of import-
ance is the fact that this research utilized an animal
model of asthma. Whilst the murine asthma model is
often and regularly used in research, relating these find-
ings to clinical settings remains difficult. Further clinical
investigations of PCF treatment for asthma are required
to verify and support the findings of the current study.
This was a relatively short-term study and it would be
beneficial to determine the effectiveness of PCF in the
long-term treatment of asthma. A long-term study would
provide information as to any possible long-term side
effects of PCF. In addition, we did not include a control
group that had been treated with PCF, it would be inter-
esting in future studies to investigate the action of PCF on
the healthy lung.
Conclusions
This study reveals that PCF can downregulate RORγt
and elevate Foxp3 expression, reduce IL-6, IL-17, IL-23,
TGF-β in BALF, thus restore the balance of Th17/Treg,
improve airway inflammation and reduce asthma symp-
toms. This TCM, PCF leads to less loss of body weight
in mice and more accretion of IL-23.
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